Literature DB >> 1732414

Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa.

U E Mai1, G I Perez-Perez, J B Allen, S M Wahl, M J Blaser, P D Smith.   

Abstract

The mechanism by which Helicobacter pylori, a noninvasive bacterium, initiates chronic antral gastritis in humans is unknown. We now show that H. pylori releases products with chemotactic activity for monocytes and neutrophils. This chemotactic activity was inhibited by antisera to either H. pylori whole bacteria or H. pylori-derived urease. Moreover, surface proteins extracted from H. pylori and purified H. pylori urease (a major component of the surface proteins) exhibited dose-dependent, antibody-inhibitable chemotactic activity. In addition, a synthetic 20-amino acid peptide from the NH2-terminal portion of the 61-kD subunit, but not the 30-kD subunit, of urease exhibited chemotactic activity for monocytes and neutrophils, localizing the chemotactic activity, at least in part, to the NH2 terminus of the 61-kD subunit of urease. The ability of leukocytes to chemotax to H. pylori surface proteins despite formyl-methionyl-leucyl-phenylalanine (FMLP) receptor saturation, selective inhibition of FMLP-mediated chemotaxis, or preincubation of the surface proteins with antiserum to FMLP indicated that the chemotaxis was not FMLP mediated. Finally, we identified H. pylori surface proteins and urease in the lamina propria of gastric antra from patients with H. pylori-associated gastritis but not from uninfected subjects. These findings suggest that H. pylori gastritis is initiated by mucosal absorption of urease, which expresses chemotactic activity for leukocytes by a mechanism not involving N-formylated oligopeptides.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732414      PMCID: PMC2119134          DOI: 10.1084/jem.175.2.517

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

2.  Campylobacter pyloridis--a new factor in peptic ulcer disease?

Authors:  B J Rathbone; J I Wyatt; R V Heatley
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

Review 3.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

4.  Purification and characterization of urease from Helicobacter pylori.

Authors:  B E Dunn; G P Campbell; G I Perez-Perez; M J Blaser
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

5.  Campylobacter pylori and non-ulcer dyspepsia.

Authors:  T Rokkas; C Pursey; E Uzoechina; L Dorrington; N A Simmons; M I Filipe; G E Sladen
Journal:  Am J Gastroenterol       Date:  1987-11       Impact factor: 10.864

6.  Two-dimensional gel electrophoresis and immunoblotting of Campylobacter pylori proteins.

Authors:  B E Dunn; G I Perez-Perez; M J Blaser
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

Review 7.  The clinical significance of Campylobacter pylori.

Authors:  C P Dooley; H Cohen
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

8.  Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium.

Authors:  S L Hazell; A Lee; L Brady; W Hennessy
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

9.  Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.

Authors:  P D Smith; K Ohura; H Masur; H C Lane; A S Fauci; S M Wahl
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Staphylococcus aureus-derived chemoattractant activity for human monocytes.

Authors:  A Rot; L E Henderson; E J Leonard
Journal:  J Leukoc Biol       Date:  1986-07       Impact factor: 4.962

View more
  98 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Phenotypic and functional characterisation of myofibroblasts, macrophages, and lymphocytes migrating out of the human gastric lamina propria following the loss of epithelial cells.

Authors:  K C Wu; L M Jackson; A M Galvin; T Gray; C J Hawkey; Y R Mahida
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

3.  Platelet activation In mice and human Helicobacter pylori infection.

Authors:  J I Elizalde; J Gómez; J Panés; M Lozano; M Casadevall; J Ramírez; P Pizcueta; F Marco; F D Rojas; D N Granger; J M Piqué
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Proinflammatory activity of a cecropin-like antibacterial peptide from Helicobacter pylori.

Authors:  J Bylund; T Christophe; F Boulay; T Nyström; A Karlsson; C Dahlgren
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

5.  Human primary gastric dendritic cells induce a Th1 response to H. pylori.

Authors:  D Bimczok; R H Clements; K B Waites; L Novak; D E Eckhoff; P J Mannon; P D Smith; L E Smythies
Journal:  Mucosal Immunol       Date:  2010-03-17       Impact factor: 7.313

6.  CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines.

Authors:  J E Crabtree; S M Farmery; I J Lindley; N Figura; P Peichl; D S Tompkins
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

7.  A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis.

Authors:  J Bylund; T Christophe; T Cristophe; F Boulay; A Romero; K Hellstrand; C Dahlgren
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

8.  Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant.

Authors:  S A Sharma; G G Miller; G I Perez-Perez; R S Gupta; M J Blaser
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Expression of adhesion molecules on human granulocytes after stimulation with Helicobacter pylori membrane proteins: comparison with membrane proteins from other bacteria.

Authors:  G Enders; W Brooks; N von Jan; N Lehn; E Bayerdörffer; R Hatz
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

10.  Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype.

Authors:  J E Crabtree; A Covacci; S M Farmery; Z Xiang; D S Tompkins; S Perry; I J Lindley; R Rappuoli
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.